Carb-X

Industry Innovation Series: Frontiers in Infectious Diseases Innovation

The final event in the 2025 Industry Innovation Series, ‘Frontiers in Infectious Diseases Innovation,’ offered attendees – across industry and academia – a unique opportunity to explore pioneering advances in infectious disease solutions and collaborative opportunities. Hosted in La Trobe University’s innovation centre, Eagleworks, on the Melbourne Campus, it was an evening of insightful discussion and networking, and highlighted the critical role of innovation in shaping the future of disease prevention and treatment.

What Is the Cost of Underinvesting in Health?

Every $1 invested in health yields up to $4 in economic return, yet health systems remain chronically underfunded. From antimicrobial resistance to air pollution, aid cuts and digital health gaps, the cost of inaction is mounting.

What are the societal and economic consequences of underinvesting in health and how do we begin to address them?

Leveraging Evidence and Tools to Advance AMR Policy Implementation

Under the leitmotif Taking Responsibility for Health in a Fragmenting World, the World Health Summit 2025 is bringing together leaders and changemakers from science, politics, civil society, and the private sector to catalyze collaborative and innovative solutions for key health priorities.

How are antibiotics linked to “superbugs”? | CNA Explains

Antibiotics have saved countless lives, but overuse and misuse are leading to the rise of “superbugs”, a bacteria resistant to the most powerful medications. What dangers do they pose? How can we prevent these from spreading? Here’s what you need to know.

Why is antibiotic resistance worsening with climate change?

Resistance to antibiotics could cause ten million deaths a year by 2050, according to a United Nations Development Programme report. Scientists say climate change is also driving the looming crisis. Why is there such risk and what’s being done about it?

How CARB-X is addressing AMR

Drug-resistant bacteria kill >1M people per year. This is the story about how CARB-X is helping to address the global health threat of AMR.